Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Straumann Holding AG (OTCMKTS:SAUHY) was the target of a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 7,573 shares, a drop of 87.0% from the January 15th total of 58,271 shares. Based on an average daily trading volume, of 144,538 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 144,538 shares, the days-to-cover ratio is presently 0.1 days.

Straumann Stock Up 1.3%

Shares of Straumann stock opened at $13.04 on Wednesday. Straumann has a 1 year low of $10.30 and a 1 year high of $15.00. The business has a fifty day simple moving average of $12.04 and a two-hundred day simple moving average of $11.84.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. UBS Group raised shares of Straumann from a “sell” rating to a “neutral” rating in a research report on Tuesday, November 4th. Citigroup reaffirmed a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research report on Monday, December 15th. Finally, Deutsche Bank Aktiengesellschaft upgraded Straumann from a “hold” rating to a “buy” rating in a research note on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold”.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.